Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Guardant Health, Inc. (GH)

Guardant Health grants co-CEOs 465,413 target PSUs each tied to relative TSR

Neutral Impact 3 of 5 shareholder Written later

Guardant Health's board approved performance-based restricted stock unit awards to co-CEOs Helmy Eltoukhy and AmirAli Talasaz, each with a target of 465,413 PSUs. The awards pay out only if the company's total shareholder return beats a set percentile versus S&P 500 constituents over three-year and five-year periods, so the grants create no value unless relative returns meet those thresholds.

Key points

  • Each co-CEO received a grant of 465,413 PSUs at target, approved November 2, 2026.
  • 25% of target PSUs cover a three-year period (June 1, 2026 to May 31, 2029); 75% cover a five-year period (June 1, 2026 to May 31, 2031).
  • Payout ranges from 0% of target below the 40th percentile to 250% at or above the 90th percentile; total vesting is capped at 250% of target.

The filing

CompanyGuardant Health, Inc. (GH)
Form8-K, current report
Filed with the SECNov 3, 2026, 8:19 AM ET
Accession number0001193125-26-444416

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.